Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Non-Current Assets (2016 - 2025)

Phibro Animal Health has reported Non-Current Assets over the past 13 years, most recently at $543.4 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $543.4 million for Q4 2025, up 0.74% from a year ago — trailing twelve months through Dec 2025 was $2.2 billion (up 28.67% YoY), and the annual figure for FY2025 was $550.3 million, up 44.36%.
  • Non-Current Assets for Q4 2025 was $543.4 million at Phibro Animal Health, down from $549.7 million in the prior quarter.
  • Over the last five years, Non-Current Assets for PAHC hit a ceiling of $550.3 million in Q2 2025 and a floor of $333.3 million in Q1 2021.
  • Median Non-Current Assets over the past 5 years was $380.7 million (2022), compared with a mean of $413.1 million.
  • Biggest five-year swings in Non-Current Assets: decreased 1.36% in 2021 and later soared 44.36% in 2025.
  • Phibro Animal Health's Non-Current Assets stood at $340.3 million in 2021, then rose by 11.69% to $380.1 million in 2022, then grew by 1.57% to $386.1 million in 2023, then skyrocketed by 39.69% to $539.4 million in 2024, then grew by 0.74% to $543.4 million in 2025.
  • The last three reported values for Non-Current Assets were $543.4 million (Q4 2025), $549.7 million (Q3 2025), and $550.3 million (Q2 2025) per Business Quant data.